Generic drugs and original drugs of pemetinib/pemetinib, how should patients choose?
Pemigatinib/ Pemigatinib is an innovative drug for cholangiocarcinoma, giving many patients new hope. However, when choosing pemetinib, many patients face a difficult problem: should they choose the higher-priced original drug or the relatively affordable generic drug?

First of all, it needs to be clear that the original drug of pemetinib has been verified through long-term research and development and rigorous clinical trials. It represents the most advanced production technology and quality control standards, ensuring the efficacy and safety of drugs. The research and development process of original drugs requires huge investments, including a lot of money, manpower and time, which is why their prices are higher. For patients, choosing original drugs means choosing fully proven efficacy and higher safety.
However, generic drugs have obvious advantages in price. They are copied and produced according to the production process and quality standards of the original drug after the patent of the original drug expires. Although the investment in the R&D and production process of generic drugs is relatively small, it does not mean that their efficacy and safety are necessarily lower than those of the original drugs. In fact, with the continuous advancement of technology and intensified market competition, some high-quality generic drugs have become closer and closer to the original drugs in terms of efficacy and safety.
For pemetinib, whether it is an original drug or a generic drug, its core ingredients and mechanism of action are the same. Therefore, in theory, their efficacy in treating cholangiocarcinoma should be similar. However, in actual applications, due to differences in production processes, quality control, etc., there may be certain differences in drugs from different brands and manufacturers. But no matter which drug you choose, you should do it under the guidance of a doctor and make sure to purchase it through formal channels to ensure the quality and safety of the drug.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)